Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05924009 · ClinicalTrials.gov registry record · NA
Characterization of Gastric Evoked Potentials
A NA study of Healthy, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- NA
- Development phase
- 155
- Enrollment target
- 1
- Study location
NCT05924009: Recruiting NA study of Healthy, sponsored by University of Pittsburgh.
NCT05924009 is a NA study of Healthy that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 155 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05924009, a NA study of Healthy, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- NA
- Development phase
- 155 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an exploratory study that will determine and standardize how best to record gastric evoked potentials (GEPs) elicited by a non-invasive method of brain stimulation (Transcranial Magnetic Stimulation, TMS), by optimizing the TMS parameters and cortical sites necessary to evoke GEPs.
Primary Outcome
Stimulation location evoking the largest GEP response, relative to FDI hotspot location
Conditions Studied
Interventions
- PROCEDURE Transcranial Magnetic Stimulation, TMS
Study Locations (1)
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 155 participants |
| Start Date | 2023-06-17 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT05924009 shows while recruiting
NCT05924009 is an interventional study that assigns participants to a tested intervention. The registered 155 participants enrollment target is mid-sized for trials with a published cap, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (76% lower).
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Transcranial Magnetic Stimulation, TMS is the first listed.
NCT05924009 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05924009 about?
NCT05924009 is a clinical study titled "Characterization of Gastric Evoked Potentials". This is an exploratory study that will determine and standardize how best to record gastric evoked potentials (GEPs) elicited by a non-invasive method of brain stimulation (Transcranial Magnetic Stimulation, TMS), by optimizing the TMS parameters and cortical sites necessary to evoke GEPs.
What is the current status of trial NCT05924009?
This trial is currently recruiting. It is a NA study. The enrollment target is 155 participants. The study started on 2023-06-17. Estimated completion is 2026-12.
What conditions does trial NCT05924009 study?
This clinical trial studies the following conditions: Healthy.
What interventions are being tested in trial NCT05924009?
The interventions under investigation include: Transcranial Magnetic Stimulation, TMS (PROCEDURE).
Who is sponsoring clinical trial NCT05924009?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05924009 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05924009's enrollment target sits among peer trials
155 149th of 1090 higher than 942 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study
RECRUITING · NA
-
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
RECRUITING · NA
-
Medical Illustration Design Characteristic Evaluation
RECRUITING · NA
-
Sodium vs Potassium Education to Improve Vascular Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03223610 · 155 participants · Phase 1
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
- NCT05072483 · 155 participants
Natural History Study of CADASIL
- NCT05086497 · 155 participants · NA
WBSI Guided Personalized Delivery of TTFields
- NCT05412069 · 155 participants · NA
Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI